What is it about?
This study aimed to determine the distribution of chronic liver disease, associated risk factors, and its impact on gamma-glutamyl transferase (GGT) activity and alpha-fetoprotein (AFP) levels in Edo State. Method: Sixty participants were enrolled, comprising 30 diagnosed with liver disease and 30 healthy controls. Patients were recruited from Edo Central Hospital, Benin City, while controls were from the general population.
Featured Image
Photo by Bioscience Image Library by Fayette Reynolds on Unsplash
Why is it important?
Bridges the gap between knowledge and action
Perspectives
Public education on healthy lifestyles and routine medical checks is recommended to mitigate liver disease prevalence and impact.
Dr Grace Eleojo Obasuyi
University of Benin
Read the Original
This page is a summary of: CHRONIC LIVER DISEASE: DISTRIBUTION AND BIOMARKERS IMPACTS IN EDO STATE, International Journal of Medical Laboratory Research, January 2025, International Journal of Medical Laboratory Research,
DOI: 10.35503/ijmlr.2025.10107.
You can read the full text:
Contributors
The following have contributed to this page
